Baidu
map
EPIGENETICS-US 润色咨询

Epigenetics

出版年份:2006 年文章数:1762 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:2.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2022-03-30 wanderer2019

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:表观遗传
    经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2021-07-12 wanderer2019

    偏重的研究方向:RNA甲基化
    经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    什么是协同作用?什么是相加作用?两者有什么区别?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    如何计算相关性?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2014-02-04 sunzju

    审稿速度:3.0
    经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2020-03-23 starry

    这个杂志要临床回顾性文章吗sunliang 2019-04-10 00:00:00 发表:
    刚创立不久的杂志的缘故

    sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2019-04-10 sunliang

    刚创立不久的杂志的缘故zzzzfffvvv 2018-10-10 发表::
    表遗传方面专业的杂志,怎么分区是0呢?
    zzzzfffvvv 2018-10-10 00:00:00 发表:
    表遗传方面专业的杂志,怎么分区是0呢?

    zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2018-10-10 zzzzfffvvv

    表遗传方面专业的杂志,怎么分区是0呢?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2017-07-16 wang_di98

    徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1207293, encodeId=5fd9120e293bc, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传<br>经验分享:article终于被accepted,历时近十个月,一审半年,中途催了两次,minor revision1个月,20多天被接受,功夫不负有心人,谢谢Epigenetics杂志,祝越办越好,也㊗️投稿了的小伙伴都高中!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Wed Mar 30 19:10:31 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998801, encodeId=f0c899880179, content=偏重的研究方向:RNA甲基化<br>经验分享:with editor一个月了,好慢呐,有战友投过这个期刊么,版面费多少?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Mon Jul 12 14:59:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101578, encodeId=f1f411015e834, content=什么是协同作用?什么是相加作用?两者有什么区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101577, encodeId=fc3811015e78a, content=如何计算相关性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500911, encodeId=d5085009119b, content=审稿速度:3.0<br>经验分享:13年3月投稿,6月需要补试验,11月再投,14年1月小修,2月accepted。煎熬啊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcc494900, createdName=sunzju, createdTime=Tue Feb 04 12:39:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587224, encodeId=94b858e224b6, content=这个杂志要临床回顾性文章吗<span class="quote">sunliang 2019-04-10 00:00:00 发表:<br>刚创立不久的杂志的缘故</span>, beContent=sunliang 2019-04-10 00:00:00 发表: 刚创立不久的杂志的缘故, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/3d6ef0c9f44345ca9abe5eeaa3420c7e/f52d6b5133e14c72ba9562c4eca6005c.jpg, createdBy=e7a92454592, createdName=starry, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569335, encodeId=a5d456933526, content=刚创立不久的杂志的缘故<span class="quote">zzzzfffvvv 2018-10-10 发表::<br>表遗传方面专业的杂志,怎么分区是0呢?</span><span class="quote">zzzzfffvvv 2018-10-10 00:00:00 发表:<br>表遗传方面专业的杂志,怎么分区是0呢?</span>, beContent=zzzzfffvvv 2018-10-10 发表:: 表遗传方面专业的杂志,怎么分区是0呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 10 00:00:00 CST 2019, time=2019-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561835, encodeId=10ff561835c9, content=表遗传方面专业的杂志,怎么分区是0呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 10 00:00:00 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544121, encodeId=ad0d54412126, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515423, encodeId=a50d5154231c, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:很快,10月投稿,12月小修,1月接受,3月发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75191650836, createdName=fei_2015, createdTime=Fri Sep 18 09:54:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2015-09-18 fei_2015

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:很快,10月投稿,12月小修,1月接受,3月发表

    0

共32条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map